Skip to main content

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals submits certificate

06 Oct 2023 Evaluate

Welcure Drugs & Pharmaceuticals has submitted the undertaking for confirming the payment of interest/dividend/principal obligations for non-convertible securities under Regulation 57(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter and half year ended 30th September, 2023. Further, the compliance of the same is not applicable on the Company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Redington 335.15
Adani Enterprises 2696.65
Amrapali Industries 32.23
Maxgrow India 164.55
Rashi Peripheral 633.10
View more..